HMC Capital, HealthCo & MoneyMe finalise raising terms
MoneyMe, HMC Capital and its satellite fund have released terms of their equity raisings that were afoot this week.
Healthco Healthcare and Wellness REIT (HealthCo) has announced a $231m non-renounceable entitlement offer and $89m placement, netting $320m in total as part of a deal to buy 11 Healthscope properties for $1.2bn.
The offer price was $1.35 per share, an 8.9 per cent discount to the last close.
Its headstock, HMC Capital, is raising $125m at $3.50 per share, a 4.1 per cent discount to the closing price.
Meanwhile, as earlier reported by DataRoom, MoneyMe has secured $37m at 8c a share, a 24 per cent discount to the last traded price on March 20.
However, the company told the market on Thursday that it had received a strong commitment from Somers Group, which is a substantial shareholder in Resimac and Thorn Group, and Perennial Value.
Resimac, which has Duncan Saville on the board, counts Somers as its 62 per cent shareholder.
The funds are being raised by MoneyMe to pay down $32m of debt to Pacific Equity Partners.
MoneyMe delivered a net profit for the six months to December of $9m after turning around from a loss a year ago.
The $1.1bn HMC Capital and its $400m-plus HealthCo remained in a trading halt on Wednesday as it finalised the equity raising that was fully underwritten by JPMorgan and Macquarie Capital.
HMC Capital owns 20 per cent in HealthCo while HMC Capital is 30 per cent owned by the Home Investment Consortium Trust, of which Mr Di Pilla is a director.
DataRoom revealed last year that the David Di Pilla-led HMC Capital was a suitor for the portfolio, taking on rivals Dexus Property Group and NorthWest Properties, after first reporting Goldman Sachs had been hired to sell the real estate sites.
Second round bids were due at the end of February in the competition, and HMC Capital had the backing of the acquisition of Healthscope owner Brookfield.
Medical Properties Trust purchased the Healthscope hospital properties in 2019 for $1.2bn.
The sale of the properties to MPT came after Healthscope was bought by Canadian private equity firm Brookfield for $4.4bn in 2019.
MPT bought about half of Healthscope’s real estate portfolio from Brookfield, while NorthWest Healthcare Properties REIT acquired the remainder for $1.3bn.